UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
1626
MFA Financial
MFA
$933M
| $1.39M | ﹤0.01% |
139,584
-265,956
| -66% | -$2.06M |
|
|
CHX
1627
DELISTED
ChampionX
CHX
| $1.39M | ﹤0.01% |
142,161
+69,508
| +96% | +$637K |
|
1628
Ovintiv
OVV
$16.4B
| $1.38M | ﹤0.01% |
144,933
+128,033
| +758% | +$893K |
|
1629
Kodiak Sciences
KOD
$2.84B
| $1.38M | ﹤0.01% |
25,516
+6,704
| +36% | +$378K |
|
|
ALX
1630
Alexander's
ALX
$1.41B
| $1.38M | ﹤0.01% |
5,718
-65
| -1% | -$17.4K |
|
|
BPYU
1631
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $1.37M | ﹤0.01% |
137,493
-90,731
| -40% | -$913K |
|
|
ZUO
1632
DELISTED
Zuora, Inc.
ZUO
| $1.37M | ﹤0.01% |
107,130
+20,899
| +24% | +$233K |
|
1633
Asbury Automotive
ABG
$3.85B
| $1.36M | ﹤0.01% |
17,554
-2,543
| -13% | -$171K |
|
1634
Equinor
EQNR
$92.4B
| $1.34M | ﹤0.01% |
92,339
| – | – |
|
1635
Trupanion
TRUP
$1.18B
| $1.34M | ﹤0.01% |
31,281
+5,057
| +19% | +$164K |
|
|
ALTR
1636
DELISTED
Altair Engineering Inc
ALTR
| $1.33M | ﹤0.01% |
33,568
+3,026
| +10% | +$103K |
|
1637
Ameris Bancorp
ABCB
$5.89B
| $1.33M | ﹤0.01% |
56,508
-7,887
| -12% | -$185K |
|
|
WW
1638
DELISTED
WW International
WW
| $1.33M | ﹤0.01% |
52,521
-8,034
| -13% | -$187K |
|
|
MDRX
1639
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.33M | ﹤0.01% |
196,811
-31,342
| -14% | -$203K |
|
1640
Heron Therapeutics
HRTX
$92.9M
| $1.33M | ﹤0.01% |
90,124
-918
| -1% | -$15.1K |
|
1641
Renasant Corp
RNST
$3.91B
| $1.32M | ﹤0.01% |
53,190
-201
| -0.4% | -$4.77K |
|
1642
Gibraltar Industries
ROCK
$1.49B
| $1.32M | ﹤0.01% |
27,520
+847
| +3% | +$37.7K |
|
|
ARGO
1643
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $1.32M | ﹤0.01% |
37,907
-7,721
| -17% | -$258K |
|
1644
Brinker International
EAT
$9.66B
| $1.32M | ﹤0.01% |
54,876
-4,488
| -8% | -$96.3K |
|
1645
ATI
ATI
$31B
| $1.32M | ﹤0.01% |
129,238
-39,507
| -23% | -$342K |
|
1646
Rush Enterprises Class A
RUSHA
$6.22B
| $1.32M | ﹤0.01% |
71,413
-2,428
| -3% | -$40.4K |
|
1647
Opko Health
OPK
$1.02B
| $1.31M | ﹤0.01% |
383,874
+129,527
| +51% | +$290K |
|
|
CVA
1648
DELISTED
Covanta Holding Corporation
CVA
| $1.31M | ﹤0.01% |
136,420
-39,760
| -23% | -$340K |
|
1649
Gray Television
GTN
$552M
| $1.31M | ﹤0.01% |
93,562
-21,320
| -19% | -$273K |
|
1650
Cal-Maine
CALM
$3.99B
| $1.3M | ﹤0.01% |
29,244
-3,943
| -12% | -$168K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.